Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma.

Overview
Research
Identity
Additional Document Info
View All

authors

Kwok, Christopher
Gross, Evan E
Orcutt, Delaney
Yin, Ming
Khorasanchi, Adam
Sarah P. Psutka MD MS
Hinkley, Megan
Dason, Shawn
Sundi, Debasish
Yang, Yuanquan
Yang, Yajing
Verschraegen, Claire

publication date

January 1, 2023

published in

Frontiers in oncology Journal